Time and Sales for Elite Pharmaceuticals Inc
Jul 29, 2015
Time Price Volume Market
10:50:18 0.231 625 OTO
10:44:27 0.235 21300 OTO
10:27:51 0.233 5000 OTO
10:27:51 0.234 15 OTO
10:27:45 0.2335 10000 OTO
10:27:45 0.235 2000 OTO
10:11:29 0.2375 1020 OTO
09:54:03 0.234 3500 OTO
09:53:57 0.236 4000 OTO
09:30:06 0.235 1250 OTO
09:30:05 0.24 2000 OTO
09:30:05 0.24 1000 OTO
09:30:03 0.24 2000 OTO
09:30:00 0.2375 6000 OTO
they are only monitoring participants for 48 hours (Time Frame: dose every 6 hours for 48 hours) so if they were dosing over the past month and recruited their final participant last week - it is very possible like Gordon says that the dosing is complete and data is getting finalized for submission to FDA. GETTING CLOSER!!!!!!!!
Yes, there it is - "This study is ongoing, but not recruiting participants"
to see for yourself to to - clinicaltrials.gov/ct2/show/NCT02401750?term=abuse+deterrent&rank=1
When do you think we will get news about PH III. May have finished dosing or will finish next week so will we see a PR? Will they lump it in with the announcement PR for Quarterly report conference? Or, will they give us an update during the Quarterly report conference call?
What do you think?
Time and Sales for Elite Pharmaceuticals Inc
12:21:04 0.23 2000 OTO
12:20:52 0.229 50000 OTO
11:59:54 0.225 10000 OTO
11:58:17 0.2221 6500 OTO
11:58:15 0.238 5000 OTO
11:58:12 0.24 2500 OTO
11:58:08 0.24 2500 OTO
11:57:44 0.24 2500 OTO
11:57:25 0.24 2500 OTO
11:57:12 0.24 3500 OTO
11:23:10 0.2401 2700 OTO
11:16:29 0.244 4 OTO
10:57:00 0.244 100 OTO
10:50:25 0.244 500 OTO
10:48:03 0.241 14000 OTO
10:47:55 0.241 2500 OTO
10:42:42 0.24 5000 OTO
10:28:53 0.2405 1904 OTO
10:22:34 0.24 5000 OTO
10:11:31 0.241 939 OTO
10:11:21 0.24 39061 OTO
10:04:32 0.24 530 OTO
09:56:16 0.24 500 OTO
09:56:14 0.24 1700 OTO
09:55:43 0.2425 20000 OTO
09:52:59 0.24 899 OTO
09:52:15 0.24 5000 OTO
Like I posted.... research older post and you can find that the recruiting has been ongoing since March. Those radio ads are bought in blocks of time and will run even after they have the needed patients. Also, Salt Lake is not the only location.
meifud/swissjuan.... how many more board names do you have??
No one outside of Elite has the details of the deal so you do not know and cannot present any facts associated with the deal with Epic. Give facts about the deal if you have them, give percentages, got anything substantial??
Recruiting was ongoing since March so they had the patients lined up already.
Check the older posts and you can even see the locations where the recruiting was ongoing.
Elite was just waiting on FDA guidance before the start so with patients lined up and the guidance in place it will be soon.
Last update on the Clinical Trials site was 9 June so the study should be wrapping up by 21 July or no later than 4 August as duration was to be 6 to 8 weeks.
Do the research.... J.A.Z.Z. is a pharmaceutical that executed a very successful plan and is now at $173 per share. ELTP could very likely have that same success!!!! A share price that is comparable in value regardles of share structure is very possible!!!!
I believe ELTP can follow that same path and I would be extremely happy with ELTP reaching a share price of $170 or more per share!
Estimated Enrollment: 162
Study Start Date: June 2015
Estimated Study Completion Date: August 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Thanks to other post for link to clinicaltrials
Gordon, correct, it was commented on by Bob Parker and another Unidentified Analyst but both comments were to the effect of not using a R/S but Hakim did not say the words "reverse split". To me that is a positive and would lead a person to believe that ELITE is beginning to look away from that option.
It is an opinion, spectulation. Not starting a rumor. Stating my opinion based on experience with other company.
Oh, for your other comment.... it is never a waste of money for a company to do a stock buy back plan. It reduces the outstanding shares therefore increasing the value of remaining shares.
Additionally, if you read the transcript from the last earnings call you will notice that Nasrat Hakim did NOT say the words "reverse split" throughout the whole discussion. So, it looks like that option is less likely to occur.
I am with Gordon on this one.... options for anything are there. Now any smart BOD, CEO, CFO will know that a R/S is not a good option unless all the conditions are perfect. So once ELITE starts to see the revenues coming in I believe they will find a better option like stock buyback or like the Gordon option of a merger. There is also the option of being bought out if the offer is BIG enough!